ArticleOncology letters2018

Aberrant cystatin-C expression in blood from patients with breast cancer is a suitable marker for monitoring tumor burden.

Woo Sun Kwon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.